The Effect of Plant Sterols on Vascular Function
1 other identifier
interventional
240
1 country
1
Brief Summary
The main aim of the study is to investigate, in humans, the effect of plant sterols on vascular function by measuring flow-mediated dilation (FMD). This study also aims to study the effect of plant sterols on pulse wave velocity (PWV), aortic augmentation index (Aix), central blood pressure (CBP), office blood pressure (BP), blood lipids and plasma plant sterol concentration. At last, the effects of plant sterols on z-scores of circulating biomarkers of endothelial dysfunction and low-grade inflammation will be assessed. For all study outcomes, effect sizes and 95% confidence intervals will be estimated. Hypothesis: Based on available evidence, it is hypothesized that plant sterols modestly increase FMD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2013
CompletedFirst Submitted
Initial submission to the registry
February 26, 2013
CompletedFirst Posted
Study publicly available on registry
March 4, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2013
CompletedOctober 28, 2013
February 1, 2013
6 months
February 26, 2013
October 25, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in flow-mediated dilation
At baseline (after 4 weeks run-in period) and after 12 weeks intervention
Secondary Outcomes (1)
Change in pulse wave velocity
At baseline (after 4 weeks run-in period) and after 12 weeks intervention
Other Outcomes (6)
Change in blood lipids
At baseline (after 4 weeks run-in period) and after 4, 8 and 12 weeks intervention
Change in plasma plant sterols
At baseline (after 4 weeks run-in period) and after 4, 8 and 12 weeks intervention
Change in plasma biomarkers of endothelial dysfunction and low-grade inflammation
At baseline (after 4 weeks run-in period) and after 12 weeks intervention
- +3 more other outcomes
Study Arms (2)
Plant Sterols
ACTIVE COMPARATORPlant Sterols
Placebo Product
PLACEBO COMPARATORPlacebo Product
Interventions
Eligibility Criteria
You may qualify if:
- Apparently healthy men and post-menopausal women
- BMI ≥ 18 and ≤ 30 kg/m2.
- Aged between 40 - 65 years.
- Having elevated LDL-cholesterol concentrations at screening (130-190 mg/dL or 3.4-4.9 mmol/L).
- Blood pressure, heart rate, haematological and clinical chemical parameters within the normal reference range as judged by the research physician
You may not qualify if:
- Having (previous) cardiovascular event(s) (stroke, TIA, angina, myocardial infarction, heart failure), systemic inflammatory conditions or diabetes mellitus.
- Use of over-the-counter and prescribed medication which may interfere with study measurements (i.e. statins, ezetimibe, fibrates, diabetic drugs, ARB and ACE inhibitors), to be judged by the Principal Investigator.
- Use of medical treatment for elevated TG concentrations.
- Use of antibiotics in the three months prior to screening.
- Currently smoking or being a non-smoker for less than 6 months and reported use of any nicotine containing products in the 6 months prior to screening and/or during the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Unilever R&Dlead
Study Sites (1)
Charité Research Organisation
Berlin, Germany
Related Publications (3)
Ras RT, Fuchs D, Koppenol WP, Schalkwijk CG, Otten-Hofman A, Garczarek U, Greyling A, Wagner F, Trautwein EA. Effect of a plant sterol-enriched spread on biomarkers of endothelial dysfunction and low-grade inflammation in hypercholesterolaemic subjects. J Nutr Sci. 2016 Dec 6;5:e44. doi: 10.1017/jns.2016.40. eCollection 2016.
PMID: 28620471DERIVEDRas RT, Koppenol WP, Garczarek U, Otten-Hofman A, Fuchs D, Wagner F, Trautwein EA. Increases in plasma plant sterols stabilize within four weeks of plant sterol intake and are independent of cholesterol metabolism. Nutr Metab Cardiovasc Dis. 2016 Apr;26(4):302-9. doi: 10.1016/j.numecd.2015.11.007. Epub 2015 Dec 12.
PMID: 26806045DERIVEDRas RT, Fuchs D, Koppenol WP, Garczarek U, Greyling A, Keicher C, Verhoeven C, Bouzamondo H, Wagner F, Trautwein EA. The effect of a low-fat spread with added plant sterols on vascular function markers: results of the Investigating Vascular Function Effects of Plant Sterols (INVEST) study. Am J Clin Nutr. 2015 Apr;101(4):733-41. doi: 10.3945/ajcn.114.102053.
PMID: 25809853DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Wieneke Koppenol, MSc
Unilever Research & Development
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2013
First Posted
March 4, 2013
Study Start
February 1, 2013
Primary Completion
August 1, 2013
Study Completion
August 1, 2013
Last Updated
October 28, 2013
Record last verified: 2013-02